YDES
YD Bio Limited · Healthcare · Biotechnology
Last
$8.76
−$0.27 (−3.05%) 4:00 PM ET
Prev close $9.03
Open $8.93
Day high $9.39
Day low $8.68
Volume 12,960
Avg vol 33,078
Mkt cap
$605.07M
Sector
Healthcare
AI report sections
YDES
YD Bio Limited
No AI report section text found yet for this symbol.
Volume vs average
Intraday (cumulative)
−38% (Below avg)
Vol/Avg: 0.62×
RSI
39.92 (Weak)
Weak (30–40)
MACD momentum
Intraday
-0.01 (Weak)
MACD: -0.06 Signal: -0.06
Short-Term
-0.11 (Weak)
MACD: -0.91 Signal: -0.80
Long-Term
-0.21 (Weak)
MACD: -1.15 Signal: -0.93
Intraday trend score 26.00

Latest news

YDES 1 article Positive: 1 Neutral: 0 Negative: 0
Positive GlobeNewswire Inc. • Dr. Ethan Shen
YD Bio Limited Expands U.S. Presence with Newly Planned California Facilities and Operations Center

YD Bio Limited plans to establish a new U.S. operations center in California to accelerate clinical development, regulatory engagement, and commercial access for cancer diagnostics and exosome-based therapeutics.

YDES YDESW biotechnology cancer detection DNA methylation operations expansion clinical development
Sentiment note

Company is expanding operations, investing in U.S. market, recruiting talent, and strategically positioning for clinical and commercial growth

News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal